Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia
NCT01823029 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 387
Last updated 2013-11-27
Summary
Extra iron may not be necessary in the treatment of iron deficiency anemia in Crohn's Disease;Oxidative Stress and Inflammation may be Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia.
Conditions
Interventions
- DRUG
-
erythropoietin
- DRUG
-
enteral nutrition.
- DRUG
-
injection of iron
Sponsors & Collaborators
-
Ministry of Health, China
collaborator OTHER_GOV -
Jinling Hospital, China
lead OTHER
Principal Investigators
-
wei ming zhu, PhD,MD · General Surgery Institute,Jinling Hospital,Nanjing,Jiangsu,China
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-07-31
- Completion
- 2013-11-30
Countries
- China
Study Locations
More Related Trials
-
Exploring the Effects of Vitamin D Supplementation on the Chronic Course of Patients With Crohn's Disease With Vitamin D Deficiency
NCT04308850 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Impact of Exclusive Enteral Nutrition Therapy on Sperm Quality of Patients With Crohn's Disease
NCT02233062 ·Status: COMPLETED ·Phase: NA
-
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027 ·Status: UNKNOWN
-
Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease
NCT04933214 ·Status: UNKNOWN
-
FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
NCT00810030 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease
NCT01540942 ·Status: COMPLETED ·Phase: NA
-
Effect of Acupuncture on Patients With Crohn's Disease in Remission
NCT04211129 ·Status: SUSPENDED ·Phase: NA
-
Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult
NCT02056418 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Vitamin D Supplementation on Infliximab Response in Patients With Crohn's Disease
NCT04606017 ·Status: COMPLETED
-
The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients
NCT06935942 ·Status: COMPLETED
-
Thalidomide in Treating Crohn's Disease
NCT02501291 ·Status: COMPLETED ·Phase: PHASE2
-
Biologics for Stricturing Crohn's Diseases
NCT05645055 ·Status: RECRUITING
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Magnetic Resonance Imaging of Motility in Crohn's 2
NCT03052465 ·Status: COMPLETED ·Phase: NA
-
Comprehensive DNA Methylation Profiling in Crohn's Disease
NCT03272152 ·Status: UNKNOWN
-
Clinical Observational Study: IBD Patients With Restless-legs-syndrome and Iron Deficiency Syndrome
NCT03457571 ·Status: COMPLETED
-
A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China
NCT06082986 ·Status: COMPLETED
-
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
NCT00572780 ·Status: COMPLETED
-
Predictors Favoring the Role of Exclusive Enteral Nutrition in Active Crohn's Disease
NCT02942511 ·Status: COMPLETED
-
Biomarkers to Predict and Monitor Response to Infliximab
NCT04655729 ·Status: UNKNOWN
-
The Effects of Parenteral ω-3 Polyunsaturated Fatty Acid on Postoperative Complications of Patients With Crohn's Disease
NCT03901937 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
NCT05387031 ·Status: RECRUITING
-
Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.
NCT05581420 ·Status: UNKNOWN ·Phase: NA
-
Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease
NCT04123990 ·Status: UNKNOWN ·Phase: NA
-
Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease
NCT04272788 ·Status: COMPLETED